tirzepatide hepatotoxicity Effect of Treatment on Hepatic Biomarkers in Patients With Metabolic Dysfunction‐Associated Steatotic Liver Disease and Type 2 Diabetes Mellitus - Arai - 2025 - Hepatology Research Advancing hepatotoxicity assessment: current advances
Description
Rare serious adverse events included gallbladder disorders and acute pancreatitis [53]
They understand that not everyone needs high doses to get results, and their approach focuses on finding the smallest effective dose for each individual under proper medical supervision
Blood sugar control improves dramatically in people with type 2 diabetes or prediabetes
Injecting in the same spot every week will cause problems
Clinicians may consider extending the time spent at lower doses if digestive side effects are problematic, as there is no requirement to rush escalation if patients are experiencing benefit and tolerating treatment reasonably well
Ozempic Primarily for glycaemic control, and its weight-loss effects are secondary
